Top compounds associated with response to LRRC8B

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	GSK1070916	GDSC1000	pan-cancer	AAC	0.16	4e-06
mRNA	Docetaxel	GDSC1000	pan-cancer	AAC	-0.16	5e-06
mRNA	navitoclax:gemcitabine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.16	6e-06
mRNA	lovastatin	CTRPv2	pan-cancer	AAC	-0.18	7e-06
mRNA	PX-12	CTRPv2	pan-cancer	AAC	0.14	7e-06
mRNA	navitoclax:sorafenib (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.17	7e-06
mRNA	vorinostat:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.17	8e-06
mRNA	rigosertib	CTRPv2	pan-cancer	AAC	0.15	8e-06
mRNA	AZD6482	GDSC1000	pan-cancer	AAC	-0.16	8e-06
mRNA	necrosulfonamide	CTRPv2	pan-cancer	AAC	0.18	1e-05

Download CSV